Abstract
Colibactin is a genotoxic molecule, produced primarily by Escherichia coli. Colibactin causes DNA damage that may lead to colorectal cancer. Here we review recent advances in the study of colibactin and propose a focus on patients with inflammatory bowel diseases (IBD) who have higher levels of colibactin-producing bacteria in their intestines.
Original language | English |
---|---|
Pages (from-to) | 874-876 |
Number of pages | 3 |
Journal | Trends in Microbiology |
Volume | 28 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2020 |
All Science Journal Classification (ASJC) codes
- Microbiology
- Microbiology (medical)
- Virology
- Infectious Diseases